Source comparison
BPC-157 Help Arthritis Research vs Standard Treatment Comparison
BPC-157 (research context) FAK-paxillin pathway modulation, angiogenesis, growth factor upregulation Potential regenerative effect in animal models. Human data absent Selective cytokine suppression without broad immune dampening Unknown. No human safety data b
This comparison does not assign a generated winner or score.
- BPC-157 (research context)
- FAK-paxillin pathway modulation, angiogenesis, growth factor upregulation
- Potential regenerative effect in animal models. Human data absent
- Selective cytokine suppression without broad immune dampening
- Unknown. No human safety data beyond 12 weeks
- Mechanistic promise without clinical validation; research-grade compound, not approved therapy
- NSAIDs (ibuprofen, naproxen)
- COX enzyme inhibition reducing prostaglandin synthesis
- No regenerative effect; chronic use may accelerate cartilage loss
- Effective short-term pain and swelling control
- GI bleeding risk, cardiovascular concerns with prolonged use
- First-line for symptom management but doesn't address disease progression
- Corticosteroid injections
- Broad anti-inflammatory via glucocorticoid receptor activation
- Temporary symptom relief; repeated injections may weaken cartilage
- Potent but non-selective inflammation suppression
- Limited to 3–4 injections/year due to cartilage damage risk
- Effective for acute flares but not disease-modifying
- Hyaluronic acid injections
- Viscosupplementation and potential anti-inflammatory effects
- Temporary lubrication; no structural repair
- Modest anti-inflammatory effect
- Well-tolerated but requires repeat injections every 6–12 months
- Mixed evidence. Some patients respond, others see no benefit
- DMARDs (methotrexate, sulfasalazine)
- Immune system modulation in autoimmune arthritis
- Slows joint damage in rheumatoid arthritis; ineffective in osteoarthritis
- Targets autoimmune inflammation specifically
- Requires monitoring for liver toxicity and infection risk
- Standard for rheumatoid arthritis; irrelevant for degenerative osteoarthritis